Articles, guides, and regulatory updates from our community.
New research explores antimicrobial peptide-functionalized nanoparticles activated by NIR light to fight biofilms in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a teen without prior diabetes. Learn what the research means for patients.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what the research suggests for patient safety.
By Peptide Association Research Team
New research explores NIR-activated antimicrobial peptide nanoparticles that may help eradicate biofilms in diabetic wounds without promoting antibiotic resistance.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
A 2026 case report reveals a child developed severe DKA after starting long-acting growth hormone therapy. Learn what clinicians and patients should know.
By Peptide Association Research Team
A landmark 2025 BMJ network meta-analysis comparing 19 obesity drugs across 262 trials reveals key trade-offs between weight loss, side effects, and heart health.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptide formulations, showing consistent quality from lab to GMP manufacturing.
By Peptide Association Research Team
New research explores how continuous spin-freeze-drying for PEGylated peptide formulations can be scaled from lab to GMP-compatible production while maintaining quality.
By Peptide Association Research Team
New research explores antimicrobial peptide nanoparticles activated by near-infrared light to combat biofilm infections in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A landmark 2026 BMJ network meta-analysis of 262 trials compares 19 obesity drugs. See what researchers found about weight loss, harms, and cardiovascular outcomes.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying of PEGylated peptides can scale to GMP manufacturing while maintaining product quality and stability.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptides, showing consistent quality from lab to GMP production. Learn what this means.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard bone repair methods. Learn what the study found.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular protein synthesis in critically ill ICU patients. Learn what researchers found.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying can scale from lab to GMP manufacturing while preserving peptide quality. Learn what this means for patients.
By Peptide Association Research Team
New research explores scalable freeze-drying for PEGylated peptide formulations. Learn what this manufacturing breakthrough may mean for peptide therapy access.
By Peptide Association Research Team
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
A major 2026 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what the evidence shows about benefits, harms, and trade-offs.
By Peptide Association Research Team
New research explores how DNA methylation and the Wnt signaling pathway may influence Alzheimer's disease progression linked to insulin resistance.
By Peptide Association Research Team
A 2026 study reveals significant geographic disparities in access to peptide-based sexual medicine therapies driven by state-level healthcare policies.
By Peptide Association Research Team
A major 2025 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what researchers found about benefits, risks, and tradeoffs.
By Peptide Association Research Team
New research finds where you live—not just federal policy—may determine your access to peptide-based sexual medicine therapies. Here's what the data shows.
By Peptide Association Research Team
A major 2025 BMJ network meta-analysis of 262 trials compares 19 obesity drugs on weight loss, safety, and cardiovascular outcomes. Here's what patients should know.
By Peptide Association Research Team
A 2026 NIDDK workshop study examines how real-world evidence can fill critical gaps in GLP-1 receptor agonist safety, effectiveness, and coverage decisions.
By Peptide Association Research Team
New 2026 research reveals wide geographic disparities in access to peptide-based sexual medicine therapies driven by state telehealth, NP, and compounding laws.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard collagen sponge delivery in large bone defect repair.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular amino acid synthesis in critically ill ICU patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune aging in hepatocellular carcinoma. Learn what the findings mean for future cancer therapy.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
A 2026 critical review examines peptide use in competitive and recreational sport, highlighting limited clinical evidence and emerging health risks. Read the findings.
By Peptide Association Research Team
New research explores how copper peptide GHK-Cu combined with glucose oxidase may support diabetic wound healing through cascade catalysis. Learn what the study found.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in hepatocellular carcinoma. Learn what the findings mean for patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in liver cancer. Learn what this study found and what it means for patients.
By Peptide Association Research Team
A 2026 critical review reveals growing peptide use in sport and bodybuilding, with limited clinical evidence and poorly defined long-term safety risks.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair, suggesting dual osteogenic and angiogenic activity in laboratory models. Learn what this means.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may restore cancer-fighting immunity suppressed by chemotherapy. Learn what this 2026 study found and why it matters.
By Peptide Association Research Team
New research explores how L-aspartic acid-derived materials may enable smarter, programmable drug delivery systems. Learn what the science says.
By Peptide Association Research Team
New research reveals how diabetes silently damages heart blood vessels and nerve signaling—raising alarms about undetected cardiac risk in diabetic patients.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair. Learn what the study found about osteogenic and angiogenic activity in this evidence-based review.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may help restore anti-tumor immunity after chemotherapy by activating dendritic cells. Learn what the study found.
By Peptide Association Research Team
A 2026 study found BPC-157 and hybrid analogs may inhibit acetylcholinesterase, a key enzyme in Alzheimer's disease. Learn what the research means.
By Peptide Association Research Team
New research links mitochondrial dysfunction and oxidative stress to gestational diabetes, placental problems, and offspring metabolic risk. Learn what the science shows.
By Peptide Association Research Team
New research on GHK-Cu peptide suggests delivery route significantly affects cognitive outcomes in aged mice. Learn what the science says and what it means for you.
By Peptide Association Research Team
New research explores oleogel systems that may improve resveratrol bioavailability. Learn what the 2026 Food Chemistry study found and what it means for supplementation.
By Peptide Association Research Team
New research identifies cathepsin B as a key driver of gut barrier breakdown in alcohol-associated liver disease. Learn what the study found and why it matters.
By Peptide Association Research Team
New research explores how GLP-1 receptor agonists affect skin biology, inflammation, wound healing, and aesthetic aging. Learn what the evidence shows.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may reduce oxidative stress and muscle damage from ischemia-reperfusion injury. Learn what the research found.
By Peptide Association Research Team
New research on GHK-Cu peptide in aged mice suggests delivery route may shape cognitive and molecular outcomes. Learn what the findings mean for aging research.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Read the findings and what they mean for research.
By Peptide Association Research Team
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy. Learn what the study found.
By Peptide Association Research Team
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's development barriers, formulation challenges, and why human clinical data remains critically limited.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
New research explores repurposed drugs targeting Alzheimer's disease pathways. Learn what the latest evidence suggests about emerging therapeutic strategies.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's biopharmaceutical challenges, pharmacokinetic gaps, and the barriers standing between preclinical promise and human trials.
By Peptide Association Research Team
A 2026 rat study found BPC 157 may reduce oxidative stress and apoptosis in lower limb ischemia-reperfusion injury. Learn what the research suggests.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines why BPC-157 lacks approved formulations, validated dosing, and completed Phase II trials despite 30+ years of preclinical data.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may protect against ischemia-reperfusion injury by reducing oxidative stress, inflammation, and cell death. Learn what the research shows.
By Peptide Association Research Team
New research explores how mitochondria-targeted peptide nanoparticles may protect the liver from ischemia-reperfusion injury. Learn what the science shows.
By Peptide Association Research Team
A 2026 review in JBJS Reviews examines the evidence, safety, and antidoping implications of injectable peptides used in sports medicine and orthopaedics.
By Peptide Association Research Team
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
A 2026 structured review examines injectable peptides for musculoskeletal recovery. Learn what the evidence, safety data, and antidoping rules mean for athletes.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
New research across 85 trials finds incretin-based therapies modestly reduce blood pressure and lower mortality in adults with obesity. Read the evidence.
By Peptide Association Research Team
New research explores retatrutide's role in CKM syndrome, showing significant weight loss, glycemic control, and cardiorenal benefits in Phase 2 trials.
By Peptide Association Research Team
New research reframes how the MASCC Risk Index predicts febrile neutropenia complications using likelihood ratios and Bayesian probability for better bedside decisions.
By Peptide Association Research Team
New research on retatrutide shows promising weight loss and metabolic results. Learn what the 2026 clinical review found about this triple hormone receptor agonist.
By Peptide Association Research Team
A 2026 review study examines nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatment strategies.
By Peptide Association Research Team
A 2026 study validated a new insulin safety protocol, boosting healthcare professionals' knowledge from 32% to 70%. Learn what the research means for patient care.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction affects female fertility and which therapeutic strategies may help restore ovarian function. Learn what the science says.
By Peptide Association Research Team
A 2026 study in Biogerontology suggests GHK-Cu may delay aging by supporting mitochondrial function and activating key longevity pathways. Learn what the research shows.
By Peptide Association Research Team
A 2026 study found BPC 157 may relax human arterial tissue via nitric oxide pathways. Learn what the research suggests and what patients should know.
By Peptide Association Research Team
A 2026 study suggests BPC 157 may relax human arterial tissue via nitric oxide signaling. Learn what the research found and what it means for vascular health.
By Peptide Association Research Team
A 2026 review study explores nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatments. Learn what the research shows.
By Peptide Association Research Team
A 2026 study found BPC 157 may promote vasorelaxation in human arterial tissue via nitric oxide pathways. Learn what the research suggests.
By Peptide Association Research Team
New research explores nanocarriers, antimicrobial peptides, and host-directed strategies as next-generation tuberculosis treatments. Learn what the science says.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in hepatocellular carcinoma. Learn what the study found and why it matters.
By Peptide Association Research Team
New zebrafish research suggests GHK-Cu peptide may reduce inflammation and oxidative stress. Learn what the study found and what it means for future research.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in liver cancer. Learn what this preclinical study found.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
New research explores an engineered inhalable powder combining niclosamide and colistin to combat drug-resistant lung infections in cystic fibrosis patients.
By Peptide Association Research Team
New research identifies a novel chemical impurity in compounded tirzepatide/B12 products. Learn what this means for patient safety and informed treatment decisions.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives inflammation and beta-cell death in type 2 diabetes—and what emerging therapies may mean for patients.
By Peptide Association Research Team
New research explores carbonless analogues of the GHK peptide using boron-nitrogen substitution. Learn what this computational study suggests about future peptide design.
By Peptide Association Research Team
New computational research explores carbonless analogues of GHK peptide, suggesting stronger copper binding and broader conformational flexibility. Learn what this means.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 may protect against heart damage from chemotherapy drugs through H2O2 regulation mechanisms.
By Peptide Association Research Team
Groundbreaking 2026 study uncovers how mitochondrial dysfunction drives inflammation and cell death in type 2 diabetes, pointing to new treatment paths.
By Peptide Association Research Team
New research examines safety profiles of approved and unapproved peptide therapies for sports medicine, revealing gaps in human safety data for popular compounds.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
Recent research explores mitochondrial-targeted liposomes containing SS-31 peptide for obesity treatment. Study shows improved fat metabolism in animal models.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 could help prevent heart damage from cancer treatment. Learn about this promising research.
By Peptide Association Research Team
Comprehensive study examines approved and unapproved peptides for musculoskeletal injuries. Learn about safety profiles and regulatory status.
By Peptide Association Research Team
Recent 2026 study shows SS-31 peptide in targeted liposomes may improve mitochondrial function in fat cells. Animal research suggests potential for obesity treatment.
By Peptide Association Research Team
New research explores how the mitochondria-targeted antioxidant peptide SS-31 may help protect cardiac function in laboratory studies of doxorubicin toxicity.
By Peptide Association Research Team
New research reveals how repurposing existing drugs could offer faster, safer therapeutic options for Alzheimer's disease treatment and prevention.
By Peptide Association Research Team
Breakthrough study reveals how SS-31 peptide and targeted liposomes may enhance fat burning by improving mitochondrial function in adipose tissue.
By Peptide Association Research Team
New research examines approved vs unapproved peptides for musculoskeletal injuries. Study reveals safety gaps in gray market compounds lacking oversight.
By Peptide Association Research Team
New research from 34 countries shows how physical and social environments accelerate brain aging by up to 9-fold, affecting 18,701 participants.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's treatment, offering hope beyond traditional therapies with known safety profiles.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team
New research on carbonless amino acids reveals modified GHK peptides may have stronger metal binding properties. Study findings and clinical implications.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer antidiabetic drugs are generally cost-effective, though access varies by income level and drug pricing.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer diabetes drugs show cost-effectiveness, but affordability varies by country income levels and treatment timing.
By Peptide Association Research Team
New research reveals how existing drugs like metformin and GLP-1 agonists may offer alternative approaches to Alzheimer's treatment through repurposing strategies.
By Peptide Association Research Team
Research reveals how mitochondria-targeted liposomes enhance thermogenesis in fat cells, offering potential obesity treatment through improved cellular metabolism.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's disease treatment, offering hope beyond current limited therapies.
By Peptide Association Research Team
New research reveals alarming connections between childhood obesity and cardiovascular disease. Study examines 381 million affected children worldwide.
By Peptide Association Research Team
Study reveals how spray-drying parameters affect injectable peptide suspension stability through advanced multimodal analysis techniques.
By Peptide Association Research Team
Recent research reveals 81% of newer antidiabetic drugs are cost-effective in developed countries, but accessibility remains limited in developing nations.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team
New research across 34 countries reveals how physical and social environmental factors accelerate brain aging by up to 9-fold in both healthy individuals and those with dementia.
By Peptide Association Research Team
New research explores repurposing existing drugs for Alzheimer's treatment, highlighting mitochondrial-targeted therapies and multi-target approaches.
By Peptide Association Research Team
New research suggests IL-15 plus thymosin alpha-1 may help reverse T cell aging in liver cancer models. Learn about this promising peptide combination study.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team
Recent study reveals tirzepatide achieved 22.7% weight loss at 52 weeks using telehealth protocol. Learn clinical implications for peptide therapy providers.
By Peptide Association Research Team
New nanoencapsulation research reveals enhanced neuroprotection against brain injury. Learn implications for thymosin beta 4 injury treatment approaches.
By Peptide Association Research Team
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 peptide reveals neuroprotective mechanisms in stroke models. Study findings on mitochondrial peptide therapy for brain health.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New research on retatrutide, a triple-agonist peptide therapy, demonstrates significant benefits for type 2 diabetes and obesity management in clinical studies.
By Peptide Association Research Team
New C. elegans study reveals Eleutheroside B's neuroprotective effects through autophagy and antioxidant mechanisms. Learn implications for peptide therapy.
By Peptide Association Research Team
Recent veterinary research on treating dry eye disease offers insights for peptide therapy providers. Find qualified doctors and learn about emerging treatments.
By Peptide Association Research Team
New study reveals safety concerns about peptides used for tendon repair and athletic enhancement. Critical insights for healthcare providers and patients.
By Peptide Association Research Team
Breakthrough research reveals enhanced bioavailability of peptide minerals through innovative encapsulation technology. Learn what this means for therapy.
By Peptide Association Research Team
Breakthrough study reveals SS-31 mitochondrial peptide therapy combined with NMN shows promise for sarcopenia treatment. Learn about NAD peptide therapy advances.
By Peptide Association Research Team
Groundbreaking study reveals how spray-drying optimization improves peptide suspension stability for therapeutic applications including tendon repair.
By Peptide Association Research Team
New research reveals stable peptide formulation methods for glatiramer acetate nanoparticles, advancing peptide therapy manufacturing and storage solutions.
By Peptide Association Research Team
New research examines cost-effectiveness of diabetes medications. Learn about peptide therapy regulation and safety considerations for healthcare providers.
By Peptide Association Research Team
Breakthrough study reveals self-assembling peptide hydrogels enhance nerve regeneration when combined with stem cells. Learn about this promising research.
By Peptide Association Research Team
Groundbreaking research reveals next-generation GLP-1 peptide therapies targeting multiple receptors for enhanced diabetes and obesity treatment outcomes.
By Peptide Association Research Team
Latest longevity peptide research explores probiotic connections to aging populations. Learn what this means for peptide therapy and clinical practice.
By Peptide Association Research Team
New research reveals how MAPK p38α inhibition overcomes FPR1 mutations affecting immune surveillance. Learn about peptide therapy implications.
By Peptide Association Research Team
Recent study reveals diammonium glycyrrhizinate and vitamin D3 combination may help treat pulmonary fibrosis through novel mechanisms. Learn about the research.
By Peptide Association Research Team
New FDA study reveals higher adverse events in compounded GLP-1 peptides vs commercial versions. Important safety insights for peptide therapy providers.
By Peptide Association Research Team
New study shows chitosan-polylysine particles create effective sustained-release system. Learn implications for peptide delivery and therapeutic applications.
By Peptide Association Research Team
New research on cepharanthine reveals potential for hepatocellular carcinoma treatment through Hippo-YAP pathway regulation. Learn about this natural compound's mechanisms.
By Peptide Association Research Team
Latest 2026 research reveals BPC-157's potential for joint repair, tendon healing, and pain management. Study findings, dosage insights, and clinical implications.
By Peptide Association Research Team
Latest 2026 study reveals BPC 157's dual role in preventing hemorrhage and thrombosis. Learn about dosage implications and clinical significance for providers.
By Peptide Association Research Team
How peptides like BPC-157, larazotide, and KPV are being studied for gastrointestinal conditions — from inflammatory bowel disease to intestinal barrier repair.
By Peptide Association Editorial Team
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
By Peptide Association Editorial Team
A comprehensive safety guide covering side effects, drug interactions, quality concerns, and red flags — essential reading for anyone considering or currently using peptide therapy.
By Peptide Association Editorial Team
The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.
By Peptide Association Editorial Team
An honest assessment of BPC-157 research — separating the extensive animal data from the limited human evidence, and what providers should tell patients asking about this popular peptide.
By Peptide Association Editorial Team
How to evaluate compounding pharmacies, understand USP standards, interpret certificates of analysis, and ensure your patients receive safe, accurately dosed peptide products.
By Peptide Association Editorial Team
How the copper-binding tripeptide GHK-Cu influences wound healing, collagen synthesis, and gene expression — and what the evidence says about its anti-aging potential.
By Peptide Association Editorial Team
How mitochondrial-derived peptides like MOTS-c and humanin intersect with NAD+ biology to influence aging, metabolic health, and cellular resilience.
By Peptide Association Editorial Team
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team
Everything you need to know about peptide therapy — from the science behind short-chain amino acids to clinical applications, delivery methods, and how to find a qualified provider.
By Peptide Association Editorial Team
How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.
By Peptide Association Editorial Team
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team